Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Imig, J. D.
Right arrow Articles by Falck, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Imig, J. D.
Right arrow Articles by Falck, J. R.

Journal of the American Society of Nephrology, Vol 7, 2364-2370, Copyright © 1996 by American Society of Nephrology

REGULAR ARTICLES

Actions of epoxygenase metabolites on the preglomerular vasculature

JD Imig, LG Navar, RJ Roman, KK Reddy and JR Falck
Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.

Epoxygenase metabolites of arachidonic acid are produced by the kidney and have been implicated in the control of renal blood flow. This study examined the preglomerular actions of various epoxyeicosatrienoic acids (EET). By use of the in vitro blood-perfused juxtamedullary nephron preparation, interlobular and afferent arteriolar diameter responses to 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET were determined. Diameters of interlobular and afferent arterioles preconstricted with 0.5 microM norepinephrine averaged 24 +/- 1 microns (N = 27) and 17 +/- 1 microns (N = 32), respectively, at a renal perfusion pressure of 100 mm Hg. Superfusion with 0.01 to 100 nM 11,12-EET caused graded increases in diameters of the interlobular and afferent arterioles. At a dose of 100 nM, 11,12-EET increased the diameters of the interlobular and afferent arterioles by 18 +/- 2% (N = 10) and 20 +/- 3% (N = 9), respectively. The vasodilatory response to 11,12-EET was stereoselective because 11,12(R,S)-EET but not 11,12(S,R)-EET increased the diameters of the interlobular and afferent arterioles. 14,15-EET had a much smaller effect and increased the diameters of the these vessels by 10%; 8,9-EET did not significantly affect vascular diameters. In contrast, 5,6-EET constricted the interlobular and afferent arterioles by 16 +/- 3% (N = 6) and 21 +/- 3% (N = 7), respectively. The corresponding diols, 5,6- DIHETE and 11,12-DIHETE, had no effect on diameters of the interlobular and afferent arterioles at concentrations up to 1 microM. The vasodilatory response to 11,12-EET was not affected by removal of the endothelium or by inhibition of cyclooxygenase with indomethacin. In contrast, the vasoconstrictor response to 5,6-EET was abolished by both removal of the endothelium or cyclooxygenase inhibition. The thromboxane/ enderoperoxide receptor inhibitor, SQ 29,548, resulted in a 60% attenuation of the afferent arteriolar vasconstriction to 5,6- EET. These results indicate that the preglomerular vasoconstriction to 5,6-EET is cyclooxygenase dependent and requires an intact endothelium, whereas the vasodilation to 11,12-EET is stereoselective and is the result of direct action of the epoxide on the preglomerular vascular smooth muscle.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J.-K. Chen, J. Chen, J. D. Imig, S. Wei, D. L. Hachey, J. S. Guthi, J. R. Falck, J. H. Capdevila, and R. C. Harris
Identification of Novel Endogenous Cytochrome P450 Arachidonate Metabolites with High Affinity for Cannabinoid Receptors
J. Biol. Chem., September 5, 2008; 283(36): 24514 - 24524.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. T. Moreland, J. D. Procknow, R. S. Sprague, J. L. Iverson, A. J. Lonigro, and A. H. Stephenson
Cyclooxygenase (COX)-1 and COX-2 Participate in 5,6-Epoxyeicosatrienoic Acid-Induced Contraction of Rabbit Intralobar Pulmonary Arteries
J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 446 - 454.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. Herrera and J. L. Garvin
Novel role of AQP-1 in NO-dependent vasorelaxation
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1443 - F1451.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Luria, S. M. Weldon, A. K. Kabcenell, R. H. Ingraham, D. Matera, H. Jiang, R. Gill, C. Morisseau, J. W. Newman, and B. D. Hammock
Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice
J. Biol. Chem., February 2, 2007; 282(5): 2891 - 2898.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
H. Huang, H.-H. Chang, Y. Xu, D. S. Reddy, J. Du, Y. Zhou, Z. Dong, J. R. Falck, and M.-H. Wang
Epoxyeicosatrienoic Acid Inhibition Alters Renal Hemodynamics During Pregnancy
Experimental Biology and Medicine, December 1, 2006; 231(11): 1744 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Sacerdoti, M. Bolognesi, M. Di Pascoli, A. Gatta, J. C. McGiff, M. L. Schwartzman, and N. G. Abraham
Rat mesenteric arterial dilator response to 11,12-epoxyeicosatrienoic acid is mediated by activating heme oxygenase
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1999 - H2002.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
M. A. Carroll, A. B. Doumad, J. Li, M. K. Cheng, J. R. Falck, and J. C. McGiff
Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F155 - F161.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhao, J. E. Quigley, J. Yuan, M.-H. Wang, Y. Zhou, and J. D. Imig
PPAR-{alpha} activator fenofibrate increases renal CYP-derived eicosanoid synthesis and improves endothelial dilator function in obese Zucker rats
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2187 - H2195.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
B. B. Davis, C. Morisseau, J. W. Newman, T. L. Pedersen, B. D. Hammock, and R. H. Weiss
Attenuation of Vascular Smooth Muscle Cell Proliferation by 1-Cyclohexyl-3-dodecyl Urea Is Independent of Soluble Epoxide Hydrolase Inhibition
J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 815 - 821.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al.
14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha}
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman
Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus
Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Fornage, C. R. Lee, P. A. Doris, M. S. Bray, G. Heiss, D. C. Zeldin, and E. Boerwinkle
The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke
Hum. Mol. Genet., October 1, 2005; 14(19): 2829 - 2837.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases
Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
E. L. Liclican, J. C. McGiff, P. L. Pedraza, N. R. Ferreri, J. R. Falck, and M. A. Carroll
Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids
Am J Physiol Renal Physiol, August 1, 2005; 289(2): F386 - F392.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
A. O. Oyekan
Differential Effects of 20-Hydroxyeicosatetraenoic Acid on Intrarenal Blood Flow in the Rat
J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1289 - 1295.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
W. Yang, K. M. Gauthier, L. M. Reddy, B. Sangras, K. K. Sharma, K. Nithipatikom, J. R. Falck, and W. B. Campbell
Stable 5,6-Epoxyeicosatrienoic Acid Analog Relaxes Coronary Arteries Through Potassium Channel Activation
Hypertension, April 1, 2005; 45(4): 681 - 686.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
E Rousseau, M. Cloutier, C. Morin, and S. Proteau
Capsazepine, a vanilloid antagonist, abolishes tonic responses induced by 20-HETE on guinea pig airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L460 - L470.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
X. Wang, M. D. Hollenberg, and R. Loutzenhiser
Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F65 - F75.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Zhao, A. Dey, O. P. Romanko, D. W. Stepp, M.-H. Wang, Y. Zhou, L. Jin, J. S. Pollock, R. C. Webb, and J. D. Imig
Decreased epoxygenase and increased epoxide hydrolase expression in the mesenteric artery of obese Zucker rats
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2005; 288(1): R188 - R196.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
Y. Zhou, H.-H. Chang, J. Du, C.-Y. Wang, Z. Dong, and M.-H. Wang
Renal epoxyeicosatrienoic acid synthesis during pregnancy
Am J Physiol Renal Physiol, January 1, 2005; 288(1): F221 - F226.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
T. C. DeLozier, C.-C. Tsao, S. J. Coulter, J. Foley, J. A. Bradbury, D. C. Zeldin, and J. A. Goldstein
CYP2C44, a New Murine CYP2C That Metabolizes Arachidonic Acid to Unique Stereospecific Products
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 845 - 854.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong
Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells
J. Biol. Chem., August 27, 2004; 279(35): 36412 - 36418.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
X. Zhao, T. Yamamoto, J. W. Newman, I.-H. Kim, T. Watanabe, B. D. Hammock, J. Stewart, J. S. Pollock, D. M. Pollock, and J. D. Imig
Soluble Epoxide Hydrolase Inhibition Protects the Kidney from Hypertension-Induced Damage
J. Am. Soc. Nephrol., May 1, 2004; 15(5): 1244 - 1253.
[Abstract] [Full Text] [PDF]

Home page
 J. Histochem. Cytochem.Home page
A. E. Enayetallah, R. A. French, M. S. Thibodeau, and D. F. Grant
Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human Tissues
J. Histochem. Cytochem., April 1, 2004; 52(4): 447 - 454.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. T. Llinas, B. T. Alexander, M. F. Capparelli, M. A. Carroll, and J. P. Granger
Cytochrome P-450 Inhibition Attenuates Hypertension Induced by Reductions in Uterine Perfusion Pressure in Pregnant Rats
Hypertension, March 1, 2004; 43(3): 623 - 628.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Fornage, E. Boerwinkle, P. A. Doris, D. Jacobs, K. Liu, and N. D. Wong
Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study
Circulation, January 27, 2004; 109(3): 335 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
I. T. Udosen, H. Jiang, H. C. Hercule, and A. O. Oyekan
Nitric oxide-epoxygenase interactions and arachidonate-induced dilation of rat renal microvessels
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2054 - H2063.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
X. Zhao, D. M. Pollock, D. C. Zeldin, and J. D. Imig
Salt-Sensitive Hypertension After Exposure to Angiotensin Is Associated With Inability to Upregulate Renal Epoxygenases
Hypertension, October 1, 2003; 42(4): 775 - 780.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. I. Pomposiello, J. Quilley, M. A. Carroll, J. R. Falck, and J. C. McGiff
5,6-Epoxyeicosatrienoic Acid Mediates the Enhanced Renal Vasodilation to Arachidonic Acid in the SHR
Hypertension, October 1, 2003; 42(4): 548 - 554.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
X. Wang, G. Trottier, and R. Loutzenhiser
Determinants of renal afferent arteriolar actions of bradykinin: evidence that multiple pathways mediate responses attributed to EDHF
Am J Physiol Renal Physiol, September 1, 2003; 285(3): F540 - F549.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
M. Miyazono, D. Zhu, R. Nemenoff, E. R. Jacobs, and E. P. Carter
Increased Epoxyeicosatrienoic Acid Formation in the Rat Kidney during Liver Cirrhosis
J. Am. Soc. Nephrol., July 1, 2003; 14(7): 1766 - 1775.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
A. H. Stephenson, R. S. Sprague, J. L. Losapio, and A. J. Lonigro
Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2153 - H2161.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
X. Zhao, D. M. Pollock, E. W. Inscho, D. C. Zeldin, and J. D. Imig
Decreased Renal Cytochrome P450 2C Enzymes and Impaired Vasodilation Are Associated With Angiotensin Salt-Sensitive Hypertension
Hypertension, March 1, 2003; 41(3): 709 - 714.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
M. Fornage, C. A. Hinojos, B. W. Nurowska, E. Boerwinkle, B. D. Hammock, C. H.P. Morisseau, and P. A. Doris
Polymorphism in Soluble Epoxide Hydrolase and Blood Pressure in Spontaneously Hypertensive Rats
Hypertension, October 1, 2002; 40(4): 485 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
F. Xu, W. O. Straub, W. Pak, P. Su, K. G. Maier, M. Yu, R. J. Roman, P. R. Ortiz De Montellano, and D. L. Kroetz
Antihypertensive effect of mechanism-based inhibition of renal arachidonic acid omega -hydroxylase activity
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2002; 283(3): R710 - R720.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 6, 2002; (2002) 261710799.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. D. Imig, X. Zhao, J. H. Capdevila, C. Morisseau, and B. D. Hammock
Soluble Epoxide Hydrolase Inhibition Lowers Arterial Blood Pressure in Angiotensin II Hypertension
Hypertension, February 1, 2002; 39(2): 690 - 694.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. J. Roman
P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function
Physiol Rev, January 1, 2002; 82(1): 131 - 185.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
S. I. Pomposiello, M. A. Carroll, J. R. Falck, and J. C. McGiff
Epoxyeicosatrienoic Acid-Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR
Hypertension, March 1, 2001; 37(3): 887 - 893.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. D. Imig
Eicosanoid regulation of the renal vasculature
Am J Physiol Renal Physiol, December 1, 2000; 279(6): F965 - F981.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
Z. Yu, F. Xu, L. M. Huse, C. Morisseau, A. J. Draper, J. W. Newman, C. Parker, L. Graham, M. M. Engler, B. D. Hammock, et al.
Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids
Circ. Res., November 24, 2000; 87(11): 992 - 998.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
M. A Carroll and J. C McGiff
A new class of lipid mediators: cytochrome P450 arachidonate metabolites
Thorax, October 1, 2000; 55(90002): 13S - 16.
[Full Text]

Home page
 Am. J. Physiol. Renal Physiol.Home page
K. D. Croft, J. C. McGiff, A. Sanchez-Mendoza, and M. A. Carroll
Angiotensin II releases 20-HETE from rat renal microvessels
Am J Physiol Renal Physiol, September 1, 2000; 279(3): F544 - F551.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
Z. Yu, L. M. Huse, P. Adler, L. Graham, J. Ma, D. C. Zeldin, and D. L. Kroetz
Increased CYP2J Expression and Epoxyeicosatrienoic Acid Formation in Spontaneously Hypertensive Rat Kidney
Mol. Pharmacol., May 1, 2000; 57(5): 1011 - 1020.
[Abstract] [Full Text]

Home page
 J. Lipid Res.Home page
J. H. Capdevila, J. R. Falck, and R. C. Harris
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
J. Lipid Res., February 1, 2000; 41(2): 163 - 181.
[Abstract] [Full Text]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. C. McGiff and J. Quilley
20-HETE and the kidney: resolution of old problems and new beginnings
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. D. Imig, E. W. Inscho, P. C. Deichmann, K. M. Reddy, and J. R. Falck
Afferent Arteriolar Vasodilation to the Sulfonimide Analog of 11,12-Epoxyeicosatrienoic Acid Involves Protein Kinase A
Hypertension, January 1, 1999; 33(1): 408 - 413.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. Su, K. M. Kaushal, and D. L. Kroetz
Inhibition of renal arachidonic acid omega -hydroxylase activity with ABT reduces blood pressure in the SHR
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1998; 275(2): R426 - R438.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
L. G. Navar
Integrating multiple paracrine regulators of renal microvascular dynamics
Am J Physiol Renal Physiol, March 1, 1998; 274(3): F433 - F444.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. J. Sinal, M. Miyata, M. Tohkin, K. Nagata, J. R. Bend, and F. J. Gonzalez
Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation
J. Biol. Chem., December 15, 2000; 275(51): 40504 - 40510.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. B. Davis, D. A. Thompson, L. L. Howard, C. Morisseau, B. D. Hammock, and R. H. Weiss
Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation
PNAS, February 19, 2002; 99(4): 2222 - 2227.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
X. Wang and R. Loutzenhiser
Determinants of renal microvascular response to ACh: afferent and efferent arteriolar actions of EDHF
Am J Physiol Renal Physiol, January 1, 2002; 282(1): F124 - F132.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673